These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of early Parkinson's disease: are complicated strategies justified? Ahlskog JE Mayo Clin Proc; 1996 Jul; 71(7):659-70. PubMed ID: 8656708 [TBL] [Abstract][Full Text] [Related]
6. Drugs for parkinsonism. Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639 [No Abstract] [Full Text] [Related]
7. Drugs for parkinsonism. Med Lett Drugs Ther; 1988 Dec; 30(781):113-6. PubMed ID: 3143051 [No Abstract] [Full Text] [Related]
8. Treatment of Parkinson's disease. From theory to practice. Ahlskog JE Postgrad Med; 1994 Apr; 95(5):52-4, 57-8, 61-4 passim. PubMed ID: 8153048 [TBL] [Abstract][Full Text] [Related]
9. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients. Libman I; Gawel MJ; Riopelle RJ; Bouchard S Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120 [TBL] [Abstract][Full Text] [Related]
10. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease. Olanow CW; Alberts MJ Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266 [No Abstract] [Full Text] [Related]
11. Treatment options for early Parkinson's disease. Stacy M; Brownlee HJ Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease. Brannan T; Yahr MD Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264 [TBL] [Abstract][Full Text] [Related]
14. L-deprenyl (selegiline) added to Sinemet CR in the management of Parkinson's disease patients with motor response fluctuations. Cedarbaum JM; Toy LH; Green-Parsons A Clin Neuropharmacol; 1991 Jun; 14(3):228-34. PubMed ID: 1906374 [TBL] [Abstract][Full Text] [Related]
15. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias. Mark MH; Sage JI Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565 [TBL] [Abstract][Full Text] [Related]
16. Update on the treatment of Parkinson's disease. Wirz D Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903 [No Abstract] [Full Text] [Related]
17. Drug management of Parkinson's disease. Kishore A; Snow BJ Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697 [TBL] [Abstract][Full Text] [Related]
19. Selegiline in the treatment of Parkinson's disease--long term experience. Yahr MD; Elizan TS; Moros D Acta Neurol Scand Suppl; 1989; 126():157-61. PubMed ID: 2515721 [TBL] [Abstract][Full Text] [Related]
20. Drug therapy for Parkinson's disease in the elderly. Robertson DR; George CF Br Med Bull; 1990 Jan; 46(1):124-46. PubMed ID: 2105818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]